Supertramp "Another thing to remember is that Leslie once...

Supertramp "Another thing to remember is that Leslie once mentioned that a big pharma company could / might make a move (to partner) from the results of half a dozen or so positive results."

Yes I don't think that a big pharma company needs to wait to see the outcome of phaze 3 trials to decide on a partnership,  as far as  double blinded trials go I am certain that the big pharma already know what the likely outcome will be of cancer patients with a Her 2 cancer receiving only the currant standard of care, (i.e. the cancer gets the better of them relatively  quickly)  therefore big pharma may decide to make decisions on the currant trials (along with a few extra recruits) without need be waiting to see what happens to a control  group.

In my thinking there is every possibility that we could see something big happen during  or shortly after  December

Now that would be nice

fp